US Bancorp’s VYNE Therapeutics VYNE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4,444	Closed	-$10.4K	–	4075
2023 Q4	$10.4K	Hold	4,444	–	–	﹤0.01%	3303
2023 Q3	$18K	Buy	+4,444	New	+$18K	﹤0.01%	2931